Last update 07 Jun 2025

QJ-19-0002

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
QJ 19 0002, QJ-19-0002, QJ190002
Target
URAT1
Action
inhibitors
Mechanism
URAT1 inhibitors(Uric acid transporter 1 inhibitors)
Therapeutic Areas
Immune System DiseasesCongenital DisordersEndocrinology and Metabolic Disease+ [2]
Active Indication
Hyperuricemia
Inactive Indication-
Originator Organization
Jiangsu Chiatai Qingjiang Pharmaceutical Co., Ltd.Jiangsu Chiatai Qingjiang Pharmaceutical Co., Ltd.
Active Organization
Jiangsu Chiatai Qingjiang Pharmaceutical Co., Ltd.Jiangsu Chiatai Qingjiang Pharmaceutical Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

4
Clinical Trials associated with QJ-19-0002
CTR20251374
/ RecruitingPhase 1
QJ-19-0002片在中国健康受试者中单中心、双盲、随机、安慰剂对照评估耐受性、安全性和药代动力学的I期临床研究
[Translation] A single-center, double-blind, randomized, placebo-controlled phase I clinical study of QJ-19-0002 tablets in healthy Chinese subjects to evaluate the tolerability, safety and pharmacokinetics
CTR20244414
/ CompletedPhase 1
QJ-19-0002片和秋水仙碱片在中国健康受试者中的药物-药物相互作用（DDI）研究
[Translation] A drug-drug interaction (DDI) study between QJ-19-0002 tablets and colchicine tablets in Chinese healthy subjects
CTR20234052
/ CompletedPhase 1
QJ-19-0002片在中国健康受试者中的耐受性和药代动力学临床试验研究
[Translation] Clinical trial study on the tolerability and pharmacokinetics of QJ-19-0002 tablets in Chinese healthy subjects
100 Clinical Results associated with QJ-19-0002
Login to view more data
100 Translational Medicine associated with QJ-19-0002
Login to view more data
100 Patents (Medical) associated with QJ-19-0002
Login to view more data
100 Deals associated with QJ-19-0002
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
HyperuricemiaPhase 1
China
Jiangsu Chiatai Qingjiang Pharmaceutical Co., Ltd.Jiangsu Chiatai Qingjiang Pharmaceutical Co., Ltd.
20 Jan 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free